Eagle Pharmaceuticals Stock Price Prediction

EGRX Stock  USD 5.97  0.05  0.83%   
The RSI of Eagle Pharmaceuticals' share price is above 70 at this time suggesting that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Eagle, making its price go up or down.

Oversold Vs Overbought


The successful prediction of Eagle Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Eagle Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Eagle Pharmaceuticals' stock price prediction:
Quarterly Earnings Growth
EPS Estimate Next Quarter
Wall Street Target Price
EPS Estimate Current Quarter
Quarterly Revenue Growth
Using Eagle Pharmaceuticals hype-based prediction, you can estimate the value of Eagle Pharmaceuticals from the perspective of Eagle Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Eagle Pharmaceuticals using Eagle Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Eagle using crowd psychology based on the activity and movement of Eagle Pharmaceuticals' stock price.

Eagle Pharmaceuticals Implied Volatility

Eagle Pharmaceuticals' implied volatility exposes the market's sentiment of Eagle Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Eagle Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Eagle Pharmaceuticals stock will not fluctuate a lot when Eagle Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Eagle Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Eagle because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Eagle Pharmaceuticals after-hype prediction price

  USD 5.88  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Eagle Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Eagle Stock please use our How to Invest in Eagle Pharmaceuticals guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eagle Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
1 Analysts
Estimates (0)
LowProjected EPSHigh

Eagle Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Eagle Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Eagle Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Eagle Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Eagle Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Eagle Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Eagle Pharmaceuticals' historical news coverage. Eagle Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.81 and 10.95, respectively. We have considered Eagle Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
After-hype Price
Eagle Pharmaceuticals is slightly risky at this time. Analysis and calculation of next after-hype price of Eagle Pharmaceuticals is based on 3 months time horizon.

Eagle Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Eagle Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eagle Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Eagle Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
7 Events / Month
7 Events / Month
In about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Eagle Pharmaceuticals Hype Timeline

Eagle Pharmaceuticals is currently traded for 5.97. The entity has historical hype elasticity of -0.14, and average elasticity to hype of competition of -0.06. Eagle is projected to decline in value after the next headline, with the price expected to drop to 5.88. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.33%, whereas the daily expected return is currently at 0.53%. The volatility of related hype on Eagle Pharmaceuticals is about 4583.31%, with the expected price after the next announcement by competition of 5.91. About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.24. Some equities with similar Price to Book (P/B) outperform the market in the long run. Eagle Pharmaceuticals has Price/Earnings To Growth (PEG) ratio of 0.91. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 7 days.
Check out Eagle Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Eagle Stock please use our How to Invest in Eagle Pharmaceuticals guide.

Eagle Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Eagle Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Eagle Pharmaceuticals' future price movements. Getting to know how Eagle Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Eagle Pharmaceuticals may potentially react to the hype associated with one of its peers.
At Risk
ANIPANI Pharmaceuticals(0.95)11 per month 0.00 (0.06) 3.11 (2.91) 10.99 
PAHCPhibro Animal Health 0.32 11 per month 2.02  0.11  4.32 (3.60) 36.18 
DCPHDeciphera Pharmaceuticals LLC 0.00 0 per month 0.00 (0.11) 3.27 (3.25) 9.66 
PBHPrestige Brand Holdings(0.87)10 per month 1.55 (0) 2.03 (1.77) 9.04 
COLLCollegium Pharmaceutical 0.46 9 per month 0.00 (0.11) 3.45 (3.40) 20.25 
SSICSilver Spike Investment(0.04)7 per month 1.05  0.17  3.14 (2.09) 9.98 
RGCRegencell Bioscience Holdings 0.49 3 per month 6.95  0.02  13.33 (13.08) 49.78 
AMPHAmphastar P(0.69)9 per month 0.00 (0.06) 2.93 (2.69) 7.42 
ALKSAlkermes Plc(0.02)7 per month 0.00 (0.14) 2.48 (2.28) 7.11 
EOLSEvolus Inc(0.47)8 per month 0.00 (0.08) 3.68 (3.97) 12.95 
PROCWProcaps Group SA 0.0001 2 per month 13.39  0  27.81 (25.45) 114.93 
DLTNFDelta 9 Cannabis 0.00 0 per month 0.00 (0.07) 17.65 (26.67) 113.33 
RAMMFRAMM Pharma Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
CVGRFCity View Green 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
BHHKFBenchmark Botanics 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
SPBBFSpeakeasy Cannabis Club 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Eagle Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Eagle price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Eagle using various technical indicators. When you analyze Eagle charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Eagle Pharmaceuticals Predictive Indicators

The successful prediction of Eagle Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Eagle Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Eagle Pharmaceuticals based on analysis of Eagle Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Eagle Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Eagle Pharmaceuticals's related companies.
 2021 2022 2023 2024 (projected)
Payables Turnover2.575.04.54.07
Days Of Inventory On Hand189.58183.75165.38173.65

Story Coverage note for Eagle Pharmaceuticals

The number of cover stories for Eagle Pharmaceuticals depends on current market conditions and Eagle Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Eagle Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Eagle Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Eagle Pharmaceuticals Short Properties

Eagle Pharmaceuticals' future price predictability will typically decrease when Eagle Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Eagle Pharmaceuticals often depends not only on the future outlook of the potential Eagle Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eagle Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding13.1 M
Cash And Short Term Investments55.3 M

Additional Tools for Eagle Stock Analysis

When running Eagle Pharmaceuticals' price analysis, check to measure Eagle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eagle Pharmaceuticals is operating at the current time. Most of Eagle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eagle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eagle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eagle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.